bioRxiv preprint doi: https://doi.org/10.1101/555003; this version posted February 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 1 The oncoprotein DEK affects the outcome of 2 PARP1/2 inhibition during replication stress 3 Magdalena Ganz1¶, Christopher Vogel1¶, Christina Czada1, Vera Jörke1, Rebecca 4 Kleiner1, Agnieszka Pierzynska-Mach2,3, Francesca Cella Zanacchi2,4, Alberto 5 Diaspro2,5, Ferdinand Kappes6, Alexander Bürkle7, and Elisa Ferrando-May1* 6 1Department of Biology, Bioimaging Center, University of Konstanz, Konstanz, 7 Germany 8 2Nanoscopy and NIC@IIT, Istituto Italiano di Tecnologia, Genoa, Italy 9 3Department of Experimental Oncology, European Institute of Oncology, Milan, Italy 10 4Biophysics Institute (IBF), National Research Council (CNR), Genoa, Italy 11 5DIFILAB, Department of Physics, University of Genoa, Genoa, Italy 12 6Xi’an Jiaotong-Liverpool University, Dushu Lake Higher Education Town, Suzhou, 13 China 14 7Department of Biology, Molecular Toxicology Group, University of Konstanz, 15 Konstanz, Germany 16 17 Short title: DEK and PARP in replication stress 18 19 * Corresponding author 20 email:
[email protected] 21 22 ¶These authors contributed equally to this work bioRxiv preprint doi: https://doi.org/10.1101/555003; this version posted February 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license.